328 related articles for article (PubMed ID: 21105780)
1. Cytolytic CD4(+) T cells in viral immunity.
Soghoian DZ; Streeck H
Expert Rev Vaccines; 2010 Dec; 9(12):1453-63. PubMed ID: 21105780
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic CD4
Sanchez-Martinez A; Perdomo-Celis F; Acevedo-Saenz L; Rugeles MT; Velilla PA
J Clin Virol; 2019 Oct; 119():17-23. PubMed ID: 31445411
[TBL] [Abstract][Full Text] [Related]
3. Cytolytic CD4 cells: Direct mediators in infectious disease and malignancy.
Brown DM
Cell Immunol; 2010; 262(2):89-95. PubMed ID: 20236628
[TBL] [Abstract][Full Text] [Related]
4. Cooperativity of HIV-Specific Cytolytic CD4 T Cells and CD8 T Cells in Control of HIV Viremia.
Johnson S; Eller M; Teigler JE; Maloveste SM; Schultz BT; Soghoian DZ; Lu R; Oster AF; Chenine AL; Alter G; Dittmer U; Marovich M; Robb ML; Michael NL; Bolton D; Streeck H
J Virol; 2015 Aug; 89(15):7494-505. PubMed ID: 25972560
[TBL] [Abstract][Full Text] [Related]
5. An HIV-1 envelope protein vaccine elicits a functionally complex human CD4+ T cell response that includes cytolytic T lymphocytes.
Stanhope PE; Liu AY; Pavlat W; Pitha PM; Clements ML; Siliciano RF
J Immunol; 1993 May; 150(10):4672-86. PubMed ID: 8097759
[TBL] [Abstract][Full Text] [Related]
6. HIV-specific CD8+ T-cell immune responses and viral replication.
Buseyne F; Rivière Y
AIDS; 1993 Nov; 7 Suppl 2():S81-5. PubMed ID: 7909230
[TBL] [Abstract][Full Text] [Related]
7. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
Munier CML; van Bockel D; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; Denyer G; Kaplan W; ; Suzuki K; Croft N; Purcell A; Tscharke D; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD
Vaccine; 2016 Oct; 34(44):5251-5261. PubMed ID: 27639281
[TBL] [Abstract][Full Text] [Related]
8. Cytokine-dependent induction of CD4+ T cells with cytotoxic potential during influenza virus infection.
Hua L; Yao S; Pham D; Jiang L; Wright J; Sawant D; Dent AL; Braciale TJ; Kaplan MH; Sun J
J Virol; 2013 Nov; 87(21):11884-93. PubMed ID: 23986597
[TBL] [Abstract][Full Text] [Related]
9. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4(+) T cells.
Norris PJ; Moffett HF; Yang OO; Kaufmann DE; Clark MJ; Addo MM; Rosenberg ES
J Virol; 2004 Aug; 78(16):8844-51. PubMed ID: 15280492
[TBL] [Abstract][Full Text] [Related]
10. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
[TBL] [Abstract][Full Text] [Related]
11. Comparative clonal analysis of human immunodeficiency virus type 1 (HIV-1)-specific CD4+ and CD8+ cytolytic T lymphocytes isolated from seronegative humans immunized with candidate HIV-1 vaccines.
Hammond SA; Bollinger RC; Stanhope PE; Quinn TC; Schwartz D; Clements ML; Siliciano RF
J Exp Med; 1992 Dec; 176(6):1531-42. PubMed ID: 1460417
[TBL] [Abstract][Full Text] [Related]
12. Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets.
Smyth MJ; Norihisa Y; Ortaldo JR
J Immunol; 1992 Jan; 148(1):55-62. PubMed ID: 1345790
[TBL] [Abstract][Full Text] [Related]
13. CD4-positive T lymphocytes are required for the generation of the primary but not the secondary CD8-positive cytolytic T lymphocyte response to herpes simplex virus in C57BL/6 mice.
Jennings SR; Bonneau RH; Smith PM; Wolcott RM; Chervenak R
Cell Immunol; 1991 Mar; 133(1):234-52. PubMed ID: 1671342
[TBL] [Abstract][Full Text] [Related]
14. The role of CD4+CD25+ regulatory T cells in viral infections.
Vahlenkamp TW; Tompkins MB; Tompkins WA
Vet Immunol Immunopathol; 2005 Oct; 108(1-2):219-25. PubMed ID: 16126280
[TBL] [Abstract][Full Text] [Related]
15. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
Kinter AL; Horak R; Sion M; Riggin L; McNally J; Lin Y; Jackson R; O'shea A; Roby G; Kovacs C; Connors M; Migueles SA; Fauci AS
AIDS Res Hum Retroviruses; 2007 Mar; 23(3):438-50. PubMed ID: 17411377
[TBL] [Abstract][Full Text] [Related]
16. Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
Kundu SK; Katzenstein D; Moses LE; Merigan TC
Proc Natl Acad Sci U S A; 1992 Dec; 89(23):11204-8. PubMed ID: 1360665
[TBL] [Abstract][Full Text] [Related]
17. Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.
Martorelli D; Muraro E; Merlo A; Turrini R; Rosato A; Dolcetti R
Int Rev Immunol; 2010 Aug; 29(4):371-402. PubMed ID: 20635880
[TBL] [Abstract][Full Text] [Related]
18. Differential susceptibility of leukocyte subsets to cytotoxic T cell killing: implications for HIV immunopathogenesis.
Liu J; Roederer M
Cytometry A; 2007 Feb; 71(2):94-104. PubMed ID: 17200952
[TBL] [Abstract][Full Text] [Related]
19. Antibody-independent antiviral function of memory CD4+ T cells in vivo requires regulatory signals from CD8+ effector T cells.
Zhong W; Roberts AD; Woodland DL
J Immunol; 2001 Aug; 167(3):1379-86. PubMed ID: 11466356
[TBL] [Abstract][Full Text] [Related]
20. Limited immune surveillance in lymphoid tissue by cytolytic CD4+ T cells during health and HIV disease.
Buggert M; Nguyen S; McLane LM; Steblyanko M; Anikeeva N; Paquin-Proulx D; Del Rio Estrada PM; Ablanedo-Terrazas Y; Noyan K; Reuter MA; Demers K; Sandberg JK; Eller MA; Streeck H; Jansson M; Nowak P; Sönnerborg A; Canaday DH; Naji A; Wherry EJ; Robb ML; Deeks SG; Reyes-Teran G; Sykulev Y; Karlsson AC; Betts MR
PLoS Pathog; 2018 Apr; 14(4):e1006973. PubMed ID: 29652923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
